Latest Articles
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment - TipRanks
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment TipRanks
Published: Oct. 27, 2025, 11:58 p.m.
Genmab’s New Phase 3 Study: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
Genmab’s New Phase 3 Study: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 11:43 p.m.
National Weather Service confirms two tornadoes in Louisiana over the weekend - WDSU
National Weather Service confirms two tornadoes in Louisiana over the weekend WDSU
Published: Oct. 27, 2025, 11:25 p.m.
Exploring Iron, Aging, and Fibrosis in Endometriosis - Bioengineer.org
Exploring Iron, Aging, and Fibrosis in Endometriosis Bioengineer.org
Published: Oct. 27, 2025, 11:10 p.m.
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 10:53 p.m.
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health - MedCity News
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health MedCity News
Published: Oct. 27, 2025, 10:24 p.m.
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study - TipRanks
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study TipRanks
Published: Oct. 27, 2025, 10:21 p.m.
EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis - TipRanks
EDAP TMS S.A. Advances HIFU Treatment Study for Rectal Endometriosis TipRanks
Published: Oct. 27, 2025, 9:42 p.m.
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic - citybuzz -
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic citybuzz -
Published: Oct. 27, 2025, 9:33 p.m.
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment - TipRanks
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 9:13 p.m.
Link copied to clipboard!